# The $632,000 Cancer Drug Being Tested Before Cancer Appears - Date: 2026-04-20 - Category: Biotech & Life Sciences Twenty patients who don't yet have active cancer received Carvykti, a $632,000 one-time CAR-T therapy. All 20 showed no detectable disease after 15 months. Medicare covers CAR-T for cancers — but not for people who aren't sick yet, and the price doesn't fit the payment model. ---